Hemostasis and Homeostasis

1967 ◽  
Vol 18 (03/04) ◽  
pp. 552-564
Author(s):  
J Roskam

IV. General Conclusions and Summary1. Normal hemostasis depends on the combined participation of 3 sorts of hemostatic factors: vascular (including its participation in local hemodynamics), platelet and blood clotting factors, the level of which when it can be assessed largely exceeds the requirements of the organism.2. Disordered hemostasis usually results from combined moderate deficiencies of at least 2 of these factors, i.e. from an “immediate” multi-causation.3. The mechanisms of homeostasis keeping hemostatic factors production at a suitable level are still unknown.4. Inversely we have a fairly good knowledge of the mechanisms neutralizing or removing from the blood stream activated blood clotting factors and hemostatic compounds released by platelets.5. When the latter mechanisms are defective and when concomitantly, blood clotting factors and platelets are sufficiently activated and/or endothelium is widely damaged, then disseminated intravascular coagulation occurs, which may lead to deficiencies of at least 2 hemostatic factors, and hence to a more or less severe bleeding tendency.6. Thus, just as such acute or subacute hemorrhagic syndromes complicating consumption coagulopathies are based upon an “immediate” multi-causation consisting of several defective hemostatic factors, they depend on a “remote” multi-causation with respect to the origin of these joint deficiencies.7. Between both of these multi-causations, immediate and remote, there is a single pathway : an important, continuous and sufficiently rapid thrombin formation.8. This explains why the best treatment of acute and subacute hemorrhagic disorders complicating disseminated intravascular coagulation is the administration of heparin.Spaet’s and our own views are only a beginning. Most of the problems concerning relations between hemostasis and homeostasis are still unsolved, for instance nature and origin of the vascular factor impeding the arrest of bleeding in idiopathic thrombocytopenic purpura, the pathogenesis of several chronic hemorrhagic conditions associated with disseminated vascular coagulation, the influence of the nervous system, catamenia, pregnancy, etc. on various hemorrhagic syndromes, etc., to say nothing of the effects of muscular exercise on von Willebrand’s disease. They deserve systematically conducted research work.

PEDIATRICS ◽  
1979 ◽  
Vol 63 (2) ◽  
pp. 337-339
Author(s):  
Ashok P. Sarnaik ◽  
Kenneth D. Stringer ◽  
Patrick F. Jewell ◽  
Sharada A. Sarnaik ◽  
Y. Ravindranath

Disseminated intravascular coagulation (DIC) may complicate hypovolemic shock secondary to trauma.1 Treatment with heparin in such cases is contraindicated because of the risk of bleeding at the site of trauma. Replacement therapy with clotting factors and platelets alone may be inadequate2 or result in volume overload in the presence of compromised renal function. We describe here a patient with multiple intraabdominal traumatic injuries whose severe bleeding diathesis secondary to DIC was successfully treated with exchange transfusion. CASE REPORT A 10-month-old black boy weighing 10 kg was brought to Children's Hospital of Michigan, Detroit with a history of grunting for three hours and "not feeling well" for three weeks.


2020 ◽  
Author(s):  
Sandeep Chakraborty

Disseminated intravascular coagulation (DIC) is a serious disorder characterized by small blood clots de- veloping throughout the bloodstream, blocking small blood vessels, depleting platelets and clotting factors leading to excessive bleeding. Lately, it is been reported that Covid19 is more of a vascular problem, than one of the lungs. Here, I enumerate studies of Lemierre’s syndrome with DIC, and also papers highlighting the Covid19 cases - this is based on my hypothesis that Covid19 is very similar to Lemierre’s Syndrome, wherein an anaerobic bacteria is enabled by a virus (SARS-Cov2/EBV) to form an abscess, from which a blood clot (carrying the bacteria) disseminates through the blood stream [1].


1967 ◽  
Vol 18 (03/04) ◽  
pp. 634-646 ◽  
Author(s):  
N Thurnherr

SummaryBlood clotting investigations have been executed in 25 patients who have undergone open heart surgery with extracorporeal circulation. A description of alterations in the activity of blood clotting factors, the fibrinolytic system, prothrombin consumption and platelets during several phases of the operation is given.


1986 ◽  
Vol 155 (1) ◽  
pp. 133-140 ◽  
Author(s):  
Jeanne PRIGENT-DACHARY ◽  
Jean-Francois FAUCON ◽  
Michel-Rene BOISSEAU ◽  
Jean DUFOURCQ

2019 ◽  
Vol 47 (4) ◽  
pp. 1810-1814
Author(s):  
Yue-Hua Huang ◽  
Dao-Bin Zhou ◽  
Bing Han ◽  
Tian Li ◽  
Shu-Jie Wang

Objective Kasabach-Merritt syndrome is a rare disease that mainly occurs in infants and adolescents. It usually manifests as disseminated intravascular coagulation and severe bleeding, and is associated with high mortality. However, its low incidence and clinical rarity in adults mean that there is currently no well-verified treatment regimen for this disease. We report on an effective novel therapeutic regimen in a patient with Kasabach-Merritt syndrome. Methods A woman with Kasabach-Merritt syndrome presented with a recurrent subcutaneous mass and disseminated intravascular coagulation, and was treated with prednisone, vincristine and thalidomide. Results This treatment regimen successfully resolved the patient’s symptoms, with tumor regression. The patient remained disease-free after 6 years of follow-up. Conclusions Prednisone combined with vincristine and thalidomide may be an effective treatment for Kasabach-Merritt syndrome, but further studies are needed to verify the use of this regimen.


Sign in / Sign up

Export Citation Format

Share Document